Form 4: Quest Diagnostics Director Receives Restricted Share Units
SEC Form 4 Filing
Tracey Doi, a director at Quest Diagnostics, acquired 1,482 restricted share units on May 16, 2024.
Summary
- On May 16, 2024, Tracey Doi, a director of Quest Diagnostics Inc., acquired 1,482 shares of common stock in the form of restricted share units.
- The shares were acquired at a price of $0.
- Following the transaction, Ms. Doi beneficially owns 5,183 shares of Quest Diagnostics common stock, which includes shares acquired via dividend reinvestment.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, and the transaction itself is neither particularly positive nor negative. It reflects standard executive compensation practices.
Positives
- The acquisition of restricted share units by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of restricted share units, a common form of executive compensation.
Stakeholder Impact
- The acquisition of restricted share units by a director may have a minor positive impact on shareholder sentiment, as it can be interpreted as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of transaction: Tracey Doi acquired 1,482 restricted share units. |
| 05/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.